

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glucuronate metabolic process (GO:0019585) | 7.18849212 |
| 2 | uronic acid metabolic process (GO:0006063) | 7.18849212 |
| 3 | cellular glucuronidation (GO:0052695) | 7.09482668 |
| 4 | xenobiotic catabolic process (GO:0042178) | 6.24877731 |
| 5 | behavioral response to nicotine (GO:0035095) | 5.53581650 |
| 6 | regulation of cholesterol biosynthetic process (GO:0045540) | 5.18411119 |
| 7 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.72824861 |
| 8 | response to nitrosative stress (GO:0051409) | 4.69285923 |
| 9 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.56302408 |
| 10 | phenylpropanoid metabolic process (GO:0009698) | 4.43151532 |
| 11 | keratinocyte development (GO:0003334) | 4.41567164 |
| 12 | potassium ion import (GO:0010107) | 4.32639953 |
| 13 | L-amino acid import (GO:0043092) | 4.13533447 |
| 14 | regulation of lipoprotein metabolic process (GO:0050746) | 4.03254575 |
| 15 | cellular ketone body metabolic process (GO:0046950) | 3.87475315 |
| 16 | positive regulation of cholesterol efflux (GO:0010875) | 3.87114774 |
| 17 | postsynaptic membrane organization (GO:0001941) | 3.80992212 |
| 18 | positive regulation of steroid biosynthetic process (GO:0010893) | 3.80920030 |
| 19 | piRNA metabolic process (GO:0034587) | 3.71118267 |
| 20 | detection of light stimulus involved in visual perception (GO:0050908) | 3.68407833 |
| 21 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.68407833 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 3.68303589 |
| 23 | ovulation cycle (GO:0042698) | 3.67784767 |
| 24 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.67465594 |
| 25 | relaxation of smooth muscle (GO:0044557) | 3.66995952 |
| 26 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.66428300 |
| 27 | relaxation of muscle (GO:0090075) | 3.65544953 |
| 28 | urinary tract smooth muscle contraction (GO:0014848) | 3.64284044 |
| 29 | generation of neurons (GO:0048699) | 3.62076089 |
| 30 | regulation of cilium movement (GO:0003352) | 3.62045619 |
| 31 | hormone catabolic process (GO:0042447) | 3.61522596 |
| 32 | ethanol oxidation (GO:0006069) | 3.57490926 |
| 33 | relaxation of cardiac muscle (GO:0055119) | 3.55904327 |
| 34 | positive regulation of cholesterol transport (GO:0032376) | 3.43202168 |
| 35 | positive regulation of sterol transport (GO:0032373) | 3.43202168 |
| 36 | transmission of nerve impulse (GO:0019226) | 3.42341667 |
| 37 | negative regulation of lipase activity (GO:0060192) | 3.42189372 |
| 38 | amino acid import (GO:0043090) | 3.42011774 |
| 39 | alanine transport (GO:0032328) | 3.41736227 |
| 40 | multicellular organism reproduction (GO:0032504) | 3.41207434 |
| 41 | ketone body metabolic process (GO:1902224) | 3.40029732 |
| 42 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.39194303 |
| 43 | nucleotide transmembrane transport (GO:1901679) | 3.37653881 |
| 44 | opioid receptor signaling pathway (GO:0038003) | 3.36614151 |
| 45 | positive regulation of meiosis (GO:0045836) | 3.34627934 |
| 46 | epithelial cilium movement (GO:0003351) | 3.34219398 |
| 47 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.33890513 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 3.31910010 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.31910010 |
| 50 | tryptophan catabolic process (GO:0006569) | 3.31910010 |
| 51 | negative regulation of organelle assembly (GO:1902116) | 3.28914940 |
| 52 | regulation of microtubule-based movement (GO:0060632) | 3.26486659 |
| 53 | neuron cell-cell adhesion (GO:0007158) | 3.26013028 |
| 54 | cilium movement (GO:0003341) | 3.22804789 |
| 55 | arginine catabolic process (GO:0006527) | 3.20990883 |
| 56 | glomerulus development (GO:0032835) | 3.20320386 |
| 57 | L-fucose metabolic process (GO:0042354) | 3.18301845 |
| 58 | L-fucose catabolic process (GO:0042355) | 3.18301845 |
| 59 | fucose catabolic process (GO:0019317) | 3.18301845 |
| 60 | L-serine transport (GO:0015825) | 3.18252232 |
| 61 | positive regulation of meiotic cell cycle (GO:0051446) | 3.18021859 |
| 62 | kynurenine metabolic process (GO:0070189) | 3.16469703 |
| 63 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.15128937 |
| 64 | presynaptic membrane assembly (GO:0097105) | 3.14860920 |
| 65 | organic cation transport (GO:0015695) | 3.14016777 |
| 66 | regulation of meiosis I (GO:0060631) | 3.11566078 |
| 67 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.11471227 |
| 68 | peristalsis (GO:0030432) | 3.10922050 |
| 69 | adaptation of signaling pathway (GO:0023058) | 3.09088952 |
| 70 | regulation of skeletal muscle contraction (GO:0014819) | 3.06183504 |
| 71 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04251161 |
| 72 | regulation of cholesterol metabolic process (GO:0090181) | 3.03033981 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 2.99223947 |
| 74 | amine catabolic process (GO:0009310) | 2.99223947 |
| 75 | negative regulation of astrocyte differentiation (GO:0048712) | 2.97666712 |
| 76 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.97354113 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97111134 |
| 78 | kidney mesenchyme development (GO:0072074) | 2.95364445 |
| 79 | cornea development in camera-type eye (GO:0061303) | 2.95061079 |
| 80 | axon ensheathment in central nervous system (GO:0032291) | 2.91063546 |
| 81 | central nervous system myelination (GO:0022010) | 2.91063546 |
| 82 | neuronal action potential propagation (GO:0019227) | 2.90462318 |
| 83 | carnitine metabolic process (GO:0009437) | 2.90378406 |
| 84 | atrial cardiac muscle cell action potential (GO:0086014) | 2.89697761 |
| 85 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.89591374 |
| 86 | indolalkylamine metabolic process (GO:0006586) | 2.89140494 |
| 87 | axoneme assembly (GO:0035082) | 2.87874683 |
| 88 | cell differentiation involved in metanephros development (GO:0072202) | 2.87644654 |
| 89 | gap junction assembly (GO:0016264) | 2.86010134 |
| 90 | protein neddylation (GO:0045116) | 2.85461685 |
| 91 | DNA methylation involved in gamete generation (GO:0043046) | 2.85459123 |
| 92 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.84153902 |
| 93 | sulfation (GO:0051923) | 2.84045790 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 2.82442784 |
| 95 | axonemal dynein complex assembly (GO:0070286) | 2.82045894 |
| 96 | negative regulation of heart rate (GO:0010459) | 2.81200446 |
| 97 | Notch signaling involved in heart development (GO:0061314) | 2.80704917 |
| 98 | exogenous drug catabolic process (GO:0042738) | 2.79802190 |
| 99 | presynaptic membrane organization (GO:0097090) | 2.76944720 |
| 100 | sensory perception of smell (GO:0007608) | 2.76478931 |
| 101 | nonmotile primary cilium assembly (GO:0035058) | 2.76035802 |
| 102 | one-carbon compound transport (GO:0019755) | 2.75550284 |
| 103 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.74973439 |
| 104 | mechanosensory behavior (GO:0007638) | 2.74658042 |
| 105 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.74406439 |
| 106 | positive regulation of chemokine secretion (GO:0090197) | 2.74094663 |
| 107 | flavonoid metabolic process (GO:0009812) | 2.73288107 |
| 108 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.73117722 |
| 109 | neural tube formation (GO:0001841) | 2.72471871 |
| 110 | metanephric mesenchyme development (GO:0072075) | 2.72147490 |
| 111 | photoreceptor cell maintenance (GO:0045494) | 2.71613566 |
| 112 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.71261710 |
| 113 | negative regulation of telomere maintenance (GO:0032205) | 2.70229318 |
| 114 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.69943383 |
| 115 | positive regulation of steroid metabolic process (GO:0045940) | 2.69854380 |
| 116 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.69671945 |
| 117 | C4-dicarboxylate transport (GO:0015740) | 2.68301734 |
| 118 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.68256539 |
| 119 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.67816021 |
| 120 | synaptic transmission, cholinergic (GO:0007271) | 2.67264858 |
| 121 | regulation of timing of cell differentiation (GO:0048505) | 2.66436575 |
| 122 | kidney morphogenesis (GO:0060993) | 2.65470073 |
| 123 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.61839407 |
| 124 | serine transport (GO:0032329) | 2.61114452 |
| 125 | tryptophan metabolic process (GO:0006568) | 2.60924898 |
| 126 | L-ascorbic acid metabolic process (GO:0019852) | 2.60770798 |
| 127 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60010793 |
| 128 | endothelium development (GO:0003158) | 2.59169910 |
| 129 | layer formation in cerebral cortex (GO:0021819) | 2.56306444 |
| 130 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.55761808 |
| 131 | neurotransmitter metabolic process (GO:0042133) | 2.55313504 |
| 132 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.55267399 |
| 133 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.54940233 |
| 134 | neuronal stem cell maintenance (GO:0097150) | 2.53561675 |
| 135 | protein polyglutamylation (GO:0018095) | 2.52721800 |
| 136 | negative regulation of neurotransmitter transport (GO:0051589) | 2.52569182 |
| 137 | sulfur amino acid catabolic process (GO:0000098) | 2.52390185 |
| 138 | benzene-containing compound metabolic process (GO:0042537) | 2.52196661 |
| 139 | retinal cone cell development (GO:0046549) | 2.51162543 |
| 140 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.50460366 |
| 141 | thrombin receptor signaling pathway (GO:0070493) | 2.48905423 |
| 142 | potassium ion homeostasis (GO:0055075) | 2.48875537 |
| 143 | import into cell (GO:0098657) | 2.48379682 |
| 144 | positive regulation of mast cell activation (GO:0033005) | 2.48292973 |
| 145 | gamma-aminobutyric acid transport (GO:0015812) | 2.48074151 |
| 146 | regulation of response to food (GO:0032095) | 2.46821094 |
| 147 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.46708128 |
| 148 | regulation of cholesterol efflux (GO:0010874) | 2.46599069 |
| 149 | regulation of chemokine secretion (GO:0090196) | 2.46232299 |
| 150 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.45955420 |
| 151 | regulation of hippo signaling (GO:0035330) | 2.45715703 |
| 152 | regulation of collateral sprouting (GO:0048670) | 2.44192180 |
| 153 | artery smooth muscle contraction (GO:0014824) | 2.43250569 |
| 154 | vocalization behavior (GO:0071625) | 2.43090062 |
| 155 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.42348719 |
| 156 | autophagic vacuole fusion (GO:0000046) | 2.42230417 |
| 157 | aggressive behavior (GO:0002118) | 2.41704142 |
| 158 | regulation of female receptivity (GO:0045924) | 2.41531625 |
| 159 | synaptic vesicle maturation (GO:0016188) | 2.41192515 |
| 160 | acrosome reaction (GO:0007340) | 2.40422915 |
| 161 | neurotransmitter biosynthetic process (GO:0042136) | 2.40320494 |
| 162 | male meiosis I (GO:0007141) | 2.39854030 |
| 163 | dopamine transport (GO:0015872) | 2.39411456 |
| 164 | lymph vessel development (GO:0001945) | 2.39039615 |
| 165 | phasic smooth muscle contraction (GO:0014821) | 2.38914404 |
| 166 | negative regulation of response to food (GO:0032096) | 2.38704163 |
| 167 | negative regulation of appetite (GO:0032099) | 2.38704163 |
| 168 | regulation of female gonad development (GO:2000194) | 2.38141924 |
| 169 | DNA deamination (GO:0045006) | 2.36653848 |
| 170 | nucleotide transport (GO:0006862) | 2.36565896 |
| 171 | ethanol metabolic process (GO:0006067) | 2.36506384 |
| 172 | drug catabolic process (GO:0042737) | 2.36440625 |
| 173 | sperm motility (GO:0030317) | 2.36104918 |
| 174 | negative regulation of smooth muscle contraction (GO:0045986) | 2.35980908 |
| 175 | glutathione derivative metabolic process (GO:1901685) | 2.35959916 |
| 176 | glutathione derivative biosynthetic process (GO:1901687) | 2.35959916 |
| 177 | cell communication by electrical coupling (GO:0010644) | 2.35501652 |
| 178 | auditory receptor cell stereocilium organization (GO:0060088) | 2.34555459 |
| 179 | indole-containing compound metabolic process (GO:0042430) | 2.34159988 |
| 180 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.33953068 |
| 181 | otic vesicle formation (GO:0030916) | 2.33797898 |
| 182 | negative regulation of protein localization to cell surface (GO:2000009) | 2.33771204 |
| 183 | phagocytosis, recognition (GO:0006910) | 2.31749710 |
| 184 | tonic smooth muscle contraction (GO:0014820) | 2.31730007 |
| 185 | alkaloid metabolic process (GO:0009820) | 2.30465566 |
| 186 | regulation of cardioblast proliferation (GO:0003264) | 2.29551870 |
| 187 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.29551870 |
| 188 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.28728568 |
| 189 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.27864618 |
| 190 | sodium ion export (GO:0071436) | 2.27511873 |
| 191 | cGMP-mediated signaling (GO:0019934) | 2.27346416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.11553413 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09019757 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.02106386 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.97897967 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68549644 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.53982196 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.48919481 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.32376659 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.29903431 |
| 10 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29876315 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23659349 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.10006109 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.10006109 |
| 14 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.05162191 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05043223 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03698789 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.03342431 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.00184185 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99001003 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98444704 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89491316 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86581443 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85282950 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.84083373 |
| 25 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.80046323 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73265424 |
| 27 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.73100957 |
| 28 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73100957 |
| 29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.71204691 |
| 30 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.71204691 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63835530 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.62828934 |
| 33 | EWS_26573619_Chip-Seq_HEK293_Human | 1.62589565 |
| 34 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61681098 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.60728724 |
| 36 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.60433071 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.59145321 |
| 38 | TCF4_23295773_ChIP-Seq_U87_Human | 1.57078682 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57032127 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53137479 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.52216467 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50906912 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50091053 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49743396 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49131728 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49051811 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49006784 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47876184 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.47746673 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47436658 |
| 51 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.47416026 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43326929 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42333813 |
| 54 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42058680 |
| 55 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.41100082 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40465984 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39193357 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39173752 |
| 59 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39020718 |
| 60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37764235 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34694848 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34352234 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.34086288 |
| 64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.34086288 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32702394 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32581352 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31548367 |
| 68 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31457609 |
| 69 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.29466707 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29360068 |
| 71 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.28954101 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28512465 |
| 73 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27996693 |
| 74 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.26619724 |
| 75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26550214 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25815847 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25388506 |
| 78 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25121319 |
| 79 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25121319 |
| 80 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24579111 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24121987 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24074612 |
| 83 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23917262 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22839688 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22490611 |
| 86 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21472066 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21415818 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20772200 |
| 89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19256538 |
| 90 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19124832 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18493556 |
| 92 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18294414 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17261181 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17078485 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16899901 |
| 96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.16290128 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15166442 |
| 98 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15143686 |
| 99 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.14737081 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14619301 |
| 101 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13704661 |
| 102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12664645 |
| 103 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12628254 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11922157 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09534622 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09329053 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08886325 |
| 108 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06644567 |
| 109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06644567 |
| 110 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06603298 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06186165 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03679447 |
| 113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03634921 |
| 114 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02979335 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02413069 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02054972 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01407651 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00230492 |
| 119 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99782814 |
| 120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99738470 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98696541 |
| 122 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98548375 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97926385 |
| 124 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97810561 |
| 125 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97252755 |
| 126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97114822 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97088278 |
| 128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96522734 |
| 129 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96429679 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94075057 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93287910 |
| 132 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.92788965 |
| 133 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.92788965 |
| 134 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.92788965 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92757308 |
| 136 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.92755004 |
| 137 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92634251 |
| 138 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91850019 |
| 139 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.91508920 |
| 140 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91437320 |
| 141 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90050445 |
| 142 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88199591 |
| 143 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.88155064 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87993827 |
| 145 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87080739 |
| 146 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86602669 |
| 147 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86513122 |
| 148 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86433971 |
| 149 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86263506 |
| 150 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85974084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005499_abnormal_olfactory_system | 5.97171980 |
| 2 | MP0005394_taste/olfaction_phenotype | 5.97171980 |
| 3 | MP0008789_abnormal_olfactory_epithelium | 5.10658514 |
| 4 | MP0001984_abnormal_olfaction | 5.10115986 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.72399322 |
| 6 | MP0003646_muscle_fatigue | 3.16383405 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.14907657 |
| 8 | MP0003878_abnormal_ear_physiology | 2.88859789 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.88859789 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.66048100 |
| 11 | MP0002736_abnormal_nociception_after | 2.55805109 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.49028304 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.48180041 |
| 14 | MP0004147_increased_porphyrin_level | 2.38488869 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.35284297 |
| 16 | MP0004885_abnormal_endolymph | 2.32357780 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.22116386 |
| 18 | MP0009384_cardiac_valve_regurgitation | 2.18802072 |
| 19 | MP0005410_abnormal_fertilization | 1.94776627 |
| 20 | MP0003690_abnormal_glial_cell | 1.94486241 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.93137499 |
| 22 | MP0002254_reproductive_system_inflammat | 1.92070188 |
| 23 | MP0003195_calcinosis | 1.89595366 |
| 24 | MP0004130_abnormal_muscle_cell | 1.77610133 |
| 25 | MP0004859_abnormal_synaptic_plasticity | 1.77475378 |
| 26 | MP0009745_abnormal_behavioral_response | 1.76955480 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.74357495 |
| 28 | MP0003718_maternal_effect | 1.73883497 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.72479886 |
| 30 | MP0000230_abnormal_systemic_arterial | 1.69984388 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.62875875 |
| 32 | MP0000427_abnormal_hair_cycle | 1.60142329 |
| 33 | MP0010030_abnormal_orbit_morphology | 1.59419878 |
| 34 | MP0000383_abnormal_hair_follicle | 1.54761604 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.54656898 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.54085795 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.50759291 |
| 38 | MP0002009_preneoplasia | 1.50322397 |
| 39 | MP0004270_analgesia | 1.48665546 |
| 40 | MP0002233_abnormal_nose_morphology | 1.47937253 |
| 41 | MP0003136_yellow_coat_color | 1.47156645 |
| 42 | MP0003879_abnormal_hair_cell | 1.45300494 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.41872883 |
| 44 | MP0002822_catalepsy | 1.39481160 |
| 45 | MP0002160_abnormal_reproductive_system | 1.36348280 |
| 46 | MP0001486_abnormal_startle_reflex | 1.36166655 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.36115936 |
| 48 | MP0004134_abnormal_chest_morphology | 1.35911475 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.34561718 |
| 50 | MP0001905_abnormal_dopamine_level | 1.34140233 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.32065719 |
| 52 | MP0003329_amyloid_beta_deposits | 1.31565766 |
| 53 | MP0000538_abnormal_urinary_bladder | 1.31186652 |
| 54 | MP0003633_abnormal_nervous_system | 1.29957949 |
| 55 | MP0000762_abnormal_tongue_morphology | 1.29868911 |
| 56 | MP0001485_abnormal_pinna_reflex | 1.29621942 |
| 57 | MP0002734_abnormal_mechanical_nocicepti | 1.29396669 |
| 58 | MP0000566_synostosis | 1.28772248 |
| 59 | MP0002102_abnormal_ear_morphology | 1.27751920 |
| 60 | MP0002064_seizures | 1.24986985 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.23401598 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.23164366 |
| 63 | MP0002063_abnormal_learning/memory/cond | 1.21385327 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.20149943 |
| 65 | MP0004142_abnormal_muscle_tone | 1.18256620 |
| 66 | MP0000049_abnormal_middle_ear | 1.16692630 |
| 67 | MP0010678_abnormal_skin_adnexa | 1.15258180 |
| 68 | MP0009379_abnormal_foot_pigmentation | 1.15159118 |
| 69 | MP0001664_abnormal_digestion | 1.14458916 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.13591586 |
| 71 | MP0001440_abnormal_grooming_behavior | 1.12949546 |
| 72 | MP0009840_abnormal_foam_cell | 1.12403299 |
| 73 | MP0003186_abnormal_redox_activity | 1.12113071 |
| 74 | MP0002272_abnormal_nervous_system | 1.11283586 |
| 75 | MP0001177_atelectasis | 1.10685465 |
| 76 | MP0005253_abnormal_eye_physiology | 1.10356598 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 1.10094778 |
| 78 | MP0001502_abnormal_circadian_rhythm | 1.08272051 |
| 79 | MP0003880_abnormal_central_pattern | 1.07734296 |
| 80 | MP0002332_abnormal_exercise_endurance | 1.06058407 |
| 81 | MP0009250_abnormal_appendicular_skeleto | 1.06010008 |
| 82 | MP0003787_abnormal_imprinting | 1.05899211 |
| 83 | MP0005408_hypopigmentation | 1.04754958 |
| 84 | MP0003631_nervous_system_phenotype | 1.03297212 |
| 85 | MP0005620_abnormal_muscle_contractility | 1.03130614 |
| 86 | MP0002234_abnormal_pharynx_morphology | 1.02117405 |
| 87 | MP0002557_abnormal_social/conspecific_i | 1.00939217 |
| 88 | MP0000778_abnormal_nervous_system | 1.00729612 |
| 89 | MP0008004_abnormal_stomach_pH | 1.00155696 |
| 90 | MP0005389_reproductive_system_phenotype | 0.99950152 |
| 91 | MP0003045_fibrosis | 0.99325720 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 0.98614050 |
| 93 | MP0004043_abnormal_pH_regulation | 0.98522902 |
| 94 | MP0002909_abnormal_adrenal_gland | 0.97730193 |
| 95 | MP0005171_absent_coat_pigmentation | 0.97202625 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.95536199 |
| 97 | MP0003279_aneurysm | 0.94081276 |
| 98 | MP0003698_abnormal_male_reproductive | 0.93237047 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.92415105 |
| 100 | MP0001919_abnormal_reproductive_system | 0.91928703 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.91832742 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.91421453 |
| 103 | MP0002735_abnormal_chemical_nociception | 0.90294506 |
| 104 | MP0006292_abnormal_olfactory_placode | 0.88938462 |
| 105 | MP0002752_abnormal_somatic_nervous | 0.86951118 |
| 106 | MP0008872_abnormal_physiological_respon | 0.82151128 |
| 107 | MP0001529_abnormal_vocalization | 0.82016819 |
| 108 | MP0001968_abnormal_touch/_nociception | 0.81697402 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.81608511 |
| 110 | MP0003755_abnormal_palate_morphology | 0.81365603 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.80788531 |
| 112 | MP0002090_abnormal_vision | 0.80056614 |
| 113 | MP0003941_abnormal_skin_development | 0.79586868 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.79071763 |
| 115 | MP0005195_abnormal_posterior_eye | 0.78421353 |
| 116 | MP0004085_abnormal_heartbeat | 0.78317294 |
| 117 | MP0003075_altered_response_to | 0.76967185 |
| 118 | MP0005266_abnormal_metabolism | 0.76383464 |
| 119 | MP0005310_abnormal_salivary_gland | 0.75646071 |
| 120 | MP0009697_abnormal_copulation | 0.75423151 |
| 121 | MP0005670_abnormal_white_adipose | 0.75405770 |
| 122 | MP0001970_abnormal_pain_threshold | 0.75195318 |
| 123 | MP0008569_lethality_at_weaning | 0.75154746 |
| 124 | MP0010329_abnormal_lipoprotein_level | 0.75099893 |
| 125 | MP0004484_altered_response_of | 0.74809023 |
| 126 | MP0005365_abnormal_bile_salt | 0.74346196 |
| 127 | MP0000534_abnormal_ureter_morphology | 0.73808645 |
| 128 | MP0002067_abnormal_sensory_capabilities | 0.73517053 |
| 129 | MP0000372_irregular_coat_pigmentation | 0.73255584 |
| 130 | MP0000026_abnormal_inner_ear | 0.71872438 |
| 131 | MP0002132_abnormal_respiratory_system | 0.71821132 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.71260663 |
| 133 | MP0005647_abnormal_sex_gland | 0.71023234 |
| 134 | MP0001929_abnormal_gametogenesis | 0.70874584 |
| 135 | MP0005551_abnormal_eye_electrophysiolog | 0.70721136 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.66518540 |
| 137 | MP0009046_muscle_twitch | 0.66196331 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.65806893 |
| 139 | MP0003937_abnormal_limbs/digits/tail_de | 0.64979103 |
| 140 | MP0001188_hyperpigmentation | 0.64688563 |
| 141 | MP0005164_abnormal_response_to | 0.64423101 |
| 142 | MP0003632_abnormal_nervous_system | 0.64301601 |
| 143 | MP0009053_abnormal_anal_canal | 0.63888291 |
| 144 | MP0004924_abnormal_behavior | 0.62500623 |
| 145 | MP0005386_behavior/neurological_phenoty | 0.62500623 |
| 146 | MP0004272_abnormal_basement_membrane | 0.62388719 |
| 147 | MP0001915_intracranial_hemorrhage | 0.62366166 |
| 148 | MP0004742_abnormal_vestibular_system | 0.61684088 |
| 149 | MP0001270_distended_abdomen | 0.61484181 |
| 150 | MP0001958_emphysema | 0.59775883 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.58172494 |
| 152 | MP0003137_abnormal_impulse_conducting | 0.57963223 |
| 153 | MP0002882_abnormal_neuron_morphology | 0.57361710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.68281253 |
| 2 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.93259446 |
| 3 | Aplasia of the phalanges of the hand (HP:0009802) | 4.93259446 |
| 4 | Aplasia involving bones of the extremities (HP:0009825) | 4.93259446 |
| 5 | Synostosis involving the elbow (HP:0003938) | 4.62519586 |
| 6 | Humeroradial synostosis (HP:0003041) | 4.62519586 |
| 7 | Congenital stationary night blindness (HP:0007642) | 4.49826641 |
| 8 | Pancreatic cysts (HP:0001737) | 4.43721924 |
| 9 | True hermaphroditism (HP:0010459) | 4.17659947 |
| 10 | Abnormality of the middle phalanges of the toes (HP:0010183) | 4.08383844 |
| 11 | Osteomalacia (HP:0002749) | 3.98371895 |
| 12 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.96789443 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.94637088 |
| 14 | Type II lissencephaly (HP:0007260) | 3.83861432 |
| 15 | Flat acetabular roof (HP:0003180) | 3.78143009 |
| 16 | Onycholysis (HP:0001806) | 3.61463562 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.55644733 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.55644733 |
| 19 | Abnormal tarsal ossification (HP:0008369) | 3.53049378 |
| 20 | Inability to walk (HP:0002540) | 3.49949286 |
| 21 | Vaginal fistula (HP:0004320) | 3.47552909 |
| 22 | Metaphyseal irregularity (HP:0003025) | 3.40054953 |
| 23 | Renal tubular acidosis (HP:0001947) | 3.39285946 |
| 24 | Bifid scrotum (HP:0000048) | 3.35778982 |
| 25 | Short hallux (HP:0010109) | 3.35356216 |
| 26 | Distal lower limb muscle weakness (HP:0009053) | 3.33502784 |
| 27 | Breast hypoplasia (HP:0003187) | 3.30582741 |
| 28 | Tarsal synostosis (HP:0008368) | 3.25843196 |
| 29 | Abnormality of carpal bone ossification (HP:0006257) | 3.24497143 |
| 30 | Synostosis involving bones of the lower limbs (HP:0009138) | 3.23030155 |
| 31 | Synostosis involving bones of the feet (HP:0009140) | 3.23030155 |
| 32 | Bronchomalacia (HP:0002780) | 3.21060381 |
| 33 | Decreased central vision (HP:0007663) | 3.19318989 |
| 34 | Abnormal ciliary motility (HP:0012262) | 3.10400359 |
| 35 | Fibular aplasia (HP:0002990) | 3.09137258 |
| 36 | Fragile skin (HP:0001030) | 3.06566790 |
| 37 | Nephronophthisis (HP:0000090) | 3.05391748 |
| 38 | Abnormality of the renal cortex (HP:0011035) | 3.05391415 |
| 39 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.02611303 |
| 40 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.02611303 |
| 41 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 3.01674067 |
| 42 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 3.00996568 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.96830288 |
| 44 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.96830288 |
| 45 | Lissencephaly (HP:0001339) | 2.95039687 |
| 46 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.94596368 |
| 47 | Hypoplastic scapulae (HP:0000882) | 2.94596368 |
| 48 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.94259316 |
| 49 | Absent speech (HP:0001344) | 2.88065395 |
| 50 | Split foot (HP:0001839) | 2.88043101 |
| 51 | Clumsiness (HP:0002312) | 2.84342728 |
| 52 | Cupped ribs (HP:0000887) | 2.81141753 |
| 53 | Cystic liver disease (HP:0006706) | 2.79345077 |
| 54 | Abnormality of the renal medulla (HP:0100957) | 2.79053929 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.74315699 |
| 56 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.71981639 |
| 57 | Absent/shortened dynein arms (HP:0200106) | 2.71981639 |
| 58 | Optic nerve hypoplasia (HP:0000609) | 2.69879823 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.69068461 |
| 60 | Supernumerary spleens (HP:0009799) | 2.68742665 |
| 61 | Sleep apnea (HP:0010535) | 2.63802839 |
| 62 | Diaphragmatic weakness (HP:0009113) | 2.63374150 |
| 63 | Medial flaring of the eyebrow (HP:0010747) | 2.62226078 |
| 64 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.62197866 |
| 65 | Chorioretinal atrophy (HP:0000533) | 2.58221300 |
| 66 | Turricephaly (HP:0000262) | 2.56844685 |
| 67 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.55495680 |
| 68 | Hypoplasia of the fovea (HP:0007750) | 2.55495680 |
| 69 | Hypoplastic nipples (HP:0002557) | 2.55218478 |
| 70 | Pulmonary artery stenosis (HP:0004415) | 2.54640035 |
| 71 | Abnormal foot bone ossification (HP:0010675) | 2.53164454 |
| 72 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.52223239 |
| 73 | Protruding tongue (HP:0010808) | 2.47906669 |
| 74 | Male pseudohermaphroditism (HP:0000037) | 2.46900888 |
| 75 | Aplasia of the musculature (HP:0100854) | 2.46453652 |
| 76 | Myokymia (HP:0002411) | 2.45143476 |
| 77 | Short nail (HP:0001799) | 2.44928914 |
| 78 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.43490413 |
| 79 | Congenital, generalized hypertrichosis (HP:0004540) | 2.43219360 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.43042685 |
| 81 | Abnormality of binocular vision (HP:0011514) | 2.41670423 |
| 82 | Diplopia (HP:0000651) | 2.41670423 |
| 83 | Obstructive sleep apnea (HP:0002870) | 2.40942836 |
| 84 | Congenital sensorineural hearing impairment (HP:0008527) | 2.40676879 |
| 85 | Large eyes (HP:0001090) | 2.38962015 |
| 86 | Absent toe (HP:0010760) | 2.38527712 |
| 87 | Renal tubular dysfunction (HP:0000124) | 2.37966758 |
| 88 | Abnormal hand bone ossification (HP:0010660) | 2.37752115 |
| 89 | Gait imbalance (HP:0002141) | 2.37618388 |
| 90 | Abnormal biliary tract physiology (HP:0012439) | 2.37544567 |
| 91 | Bile duct proliferation (HP:0001408) | 2.37544567 |
| 92 | Choanal stenosis (HP:0000452) | 2.37452145 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.36841281 |
| 94 | Abnormality of secondary sexual hair (HP:0009888) | 2.35866972 |
| 95 | Abnormality of the axillary hair (HP:0100134) | 2.35866972 |
| 96 | Tubular atrophy (HP:0000092) | 2.35382638 |
| 97 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.34623527 |
| 98 | Focal motor seizures (HP:0011153) | 2.34592051 |
| 99 | Stomach cancer (HP:0012126) | 2.31560300 |
| 100 | Abnormal ossification of hand bones (HP:0005921) | 2.30881525 |
| 101 | Ulnar bowing (HP:0003031) | 2.30634619 |
| 102 | Pendular nystagmus (HP:0012043) | 2.28020577 |
| 103 | Retinal dysplasia (HP:0007973) | 2.27297693 |
| 104 | Genital tract atresia (HP:0001827) | 2.26920681 |
| 105 | Keratoconus (HP:0000563) | 2.25189684 |
| 106 | Increased corneal curvature (HP:0100692) | 2.25189684 |
| 107 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.25004903 |
| 108 | Congenital primary aphakia (HP:0007707) | 2.24964003 |
| 109 | Decreased circulating renin level (HP:0003351) | 2.22342406 |
| 110 | Hemiparesis (HP:0001269) | 2.22336944 |
| 111 | Adactyly (HP:0009776) | 2.21292285 |
| 112 | Sclerocornea (HP:0000647) | 2.20795643 |
| 113 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.20330431 |
| 114 | Abnormality of the fibula (HP:0002991) | 2.20191641 |
| 115 | Vaginal atresia (HP:0000148) | 2.20067783 |
| 116 | Renal cortical cysts (HP:0000803) | 2.19826122 |
| 117 | Cerebellar dysplasia (HP:0007033) | 2.19425106 |
| 118 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.18720880 |
| 119 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.17771671 |
| 120 | Furrowed tongue (HP:0000221) | 2.17548716 |
| 121 | Pachygyria (HP:0001302) | 2.17471359 |
| 122 | Hypoplastic left heart (HP:0004383) | 2.17081883 |
| 123 | Female pseudohermaphroditism (HP:0010458) | 2.15952347 |
| 124 | Menorrhagia (HP:0000132) | 2.14560835 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 2.14324317 |
| 126 | Anencephaly (HP:0002323) | 2.13406953 |
| 127 | Hyperventilation (HP:0002883) | 2.12765958 |
| 128 | Conical tooth (HP:0000698) | 2.11930922 |
| 129 | Stridor (HP:0010307) | 2.10330554 |
| 130 | Bowed forearm bones (HP:0003956) | 2.09461319 |
| 131 | Bowing of the arm (HP:0006488) | 2.09461319 |
| 132 | Progressive inability to walk (HP:0002505) | 2.09259904 |
| 133 | Febrile seizures (HP:0002373) | 2.08521127 |
| 134 | Abnormality of the labia minora (HP:0012880) | 2.08378647 |
| 135 | Tubulointerstitial fibrosis (HP:0005576) | 2.07632219 |
| 136 | Femoral bowing (HP:0002980) | 2.07026773 |
| 137 | Long nose (HP:0003189) | 2.06900324 |
| 138 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05758142 |
| 139 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.05709990 |
| 140 | Palpebral edema (HP:0100540) | 2.00178340 |
| 141 | Widely spaced teeth (HP:0000687) | 1.98391876 |
| 142 | Gaze-evoked nystagmus (HP:0000640) | 1.98170825 |
| 143 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98125974 |
| 144 | Congenital hepatic fibrosis (HP:0002612) | 1.98070346 |
| 145 | Chronic hepatic failure (HP:0100626) | 1.97309015 |
| 146 | Microretrognathia (HP:0000308) | 1.96593225 |
| 147 | Mixed hearing impairment (HP:0000410) | 1.95898990 |
| 148 | Hypoplastic toenails (HP:0001800) | 1.95667158 |
| 149 | Broad-based gait (HP:0002136) | 1.95050636 |
| 150 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.94169385 |
| 151 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.94002913 |
| 152 | Abnormality of the dental pulp (HP:0006479) | 1.93729744 |
| 153 | Bilateral microphthalmos (HP:0007633) | 1.93521126 |
| 154 | Abnormality of the fovea (HP:0000493) | 1.92608553 |
| 155 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.92383699 |
| 156 | Arnold-Chiari malformation (HP:0002308) | 1.89650986 |
| 157 | Scanning speech (HP:0002168) | 1.88945286 |
| 158 | Polydipsia (HP:0001959) | 1.88034637 |
| 159 | Abnormal drinking behavior (HP:0030082) | 1.88034637 |
| 160 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.87786983 |
| 161 | Pseudobulbar signs (HP:0002200) | 1.87592080 |
| 162 | Rhinitis (HP:0012384) | 1.86833135 |
| 163 | Anterior segment dysgenesis (HP:0007700) | 1.84956261 |
| 164 | Progressive cerebellar ataxia (HP:0002073) | 1.84565305 |
| 165 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.84187863 |
| 166 | Patellar aplasia (HP:0006443) | 1.83654950 |
| 167 | Focal seizures (HP:0007359) | 1.82445942 |
| 168 | Hypoplastic heart (HP:0001961) | 1.80935753 |
| 169 | Abnormality of permanent molar morphology (HP:0011071) | 1.80552089 |
| 170 | Abnormality of the dental root (HP:0006486) | 1.80552089 |
| 171 | Taurodontia (HP:0000679) | 1.80552089 |
| 172 | Occipital encephalocele (HP:0002085) | 1.79551203 |
| 173 | Proximal tubulopathy (HP:0000114) | 1.79398668 |
| 174 | Rickets (HP:0002748) | 1.79185923 |
| 175 | Labial hypoplasia (HP:0000066) | 1.78784313 |
| 176 | Scrotal hypoplasia (HP:0000046) | 1.77842331 |
| 177 | Petechiae (HP:0000967) | 1.76862368 |
| 178 | Abnormality of molar morphology (HP:0011070) | 1.76037935 |
| 179 | Abnormality of molar (HP:0011077) | 1.76037935 |
| 180 | Accelerated skeletal maturation (HP:0005616) | 1.73574540 |
| 181 | Hyperglycinuria (HP:0003108) | 1.72520586 |
| 182 | Abnormality of the clitoris (HP:0000056) | 1.72322548 |
| 183 | Syncope (HP:0001279) | 1.72306340 |
| 184 | Fair hair (HP:0002286) | 1.72282655 |
| 185 | Rimmed vacuoles (HP:0003805) | 1.72153973 |
| 186 | Epileptic encephalopathy (HP:0200134) | 1.72054787 |
| 187 | Hypophosphatemic rickets (HP:0004912) | 1.71785439 |
| 188 | Metabolic alkalosis (HP:0200114) | 1.69674882 |
| 189 | Generalized tonic-clonic seizures (HP:0002069) | 1.68897011 |
| 190 | Infertility (HP:0000789) | 1.68744056 |
| 191 | Lip pit (HP:0100267) | 1.67247684 |
| 192 | Abnormality of homocysteine metabolism (HP:0010919) | 1.66808549 |
| 193 | Poor coordination (HP:0002370) | 1.66399580 |
| 194 | Intellectual disability, severe (HP:0010864) | 1.65821097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.86867204 |
| 2 | TNIK | 4.37820905 |
| 3 | BMPR1B | 4.31838528 |
| 4 | ADRBK2 | 3.36470369 |
| 5 | MAPK15 | 2.40629780 |
| 6 | FRK | 2.40372014 |
| 7 | SGK2 | 2.22944701 |
| 8 | NUAK1 | 2.21439478 |
| 9 | FER | 2.07470461 |
| 10 | WNK3 | 2.04378466 |
| 11 | OBSCN | 1.93491910 |
| 12 | SGK3 | 1.92320087 |
| 13 | MUSK | 1.91145899 |
| 14 | SGK223 | 1.90888545 |
| 15 | SGK494 | 1.90888545 |
| 16 | TGFBR1 | 1.90371054 |
| 17 | PAK3 | 1.88978219 |
| 18 | MAPK13 | 1.86452914 |
| 19 | CASK | 1.84318503 |
| 20 | LATS1 | 1.83872880 |
| 21 | SIK1 | 1.77638063 |
| 22 | MST4 | 1.77210251 |
| 23 | BMPR2 | 1.70385631 |
| 24 | EPHA4 | 1.69445074 |
| 25 | TAOK3 | 1.63282328 |
| 26 | MAP3K4 | 1.56950910 |
| 27 | PHKG2 | 1.56075546 |
| 28 | PHKG1 | 1.56075546 |
| 29 | PRPF4B | 1.53635782 |
| 30 | HIPK2 | 1.51450721 |
| 31 | CAMKK2 | 1.50958335 |
| 32 | ZAK | 1.46333318 |
| 33 | ADRBK1 | 1.40287022 |
| 34 | CAMKK1 | 1.37767627 |
| 35 | TLK1 | 1.36643041 |
| 36 | MARK3 | 1.32857430 |
| 37 | STK3 | 1.31785413 |
| 38 | STK38L | 1.31710376 |
| 39 | ERBB3 | 1.30712852 |
| 40 | MINK1 | 1.28886442 |
| 41 | SIK3 | 1.26097788 |
| 42 | MAP3K7 | 1.25414099 |
| 43 | CSNK1A1L | 1.23423850 |
| 44 | CLK1 | 1.21748238 |
| 45 | WNK4 | 1.17020043 |
| 46 | EPHB2 | 1.16869770 |
| 47 | RPS6KB2 | 1.15095781 |
| 48 | NME1 | 1.14018598 |
| 49 | NTRK3 | 1.11067008 |
| 50 | NEK2 | 1.07835361 |
| 51 | MARK1 | 1.07768343 |
| 52 | NTRK2 | 1.05501130 |
| 53 | MAP4K2 | 1.03222272 |
| 54 | PTK2B | 1.00125713 |
| 55 | PRKCE | 0.98991548 |
| 56 | MAPK12 | 0.98514466 |
| 57 | RIPK4 | 0.97927127 |
| 58 | SIK2 | 0.94668530 |
| 59 | CAMK2A | 0.91406059 |
| 60 | MAPKAPK3 | 0.89843175 |
| 61 | FGR | 0.88575146 |
| 62 | SGK1 | 0.87930497 |
| 63 | PRKCG | 0.87035956 |
| 64 | STK39 | 0.86813706 |
| 65 | PBK | 0.86666782 |
| 66 | PNCK | 0.86540599 |
| 67 | CSNK1G2 | 0.85673555 |
| 68 | OXSR1 | 0.85628002 |
| 69 | YES1 | 0.85061779 |
| 70 | INSRR | 0.84677525 |
| 71 | TYRO3 | 0.84638210 |
| 72 | NEK6 | 0.83212691 |
| 73 | MAP2K7 | 0.83168610 |
| 74 | CAMK2B | 0.79956013 |
| 75 | MAPK7 | 0.79885461 |
| 76 | ROCK1 | 0.79652678 |
| 77 | LMTK2 | 0.79010375 |
| 78 | CAMK2D | 0.77205671 |
| 79 | CDK8 | 0.76480376 |
| 80 | TNK2 | 0.75505204 |
| 81 | DAPK2 | 0.74381083 |
| 82 | PINK1 | 0.73641055 |
| 83 | PIK3CG | 0.70092942 |
| 84 | CDC42BPA | 0.69703011 |
| 85 | PKN1 | 0.69353263 |
| 86 | CAMK2G | 0.69123980 |
| 87 | MAP2K6 | 0.68179273 |
| 88 | PAK6 | 0.68033088 |
| 89 | CSF1R | 0.67760866 |
| 90 | MAP2K1 | 0.67541556 |
| 91 | CDK5 | 0.67533859 |
| 92 | CSNK1G3 | 0.66607547 |
| 93 | DYRK2 | 0.65471535 |
| 94 | MAP3K3 | 0.65059078 |
| 95 | FGFR3 | 0.64447456 |
| 96 | WNK1 | 0.64423841 |
| 97 | CAMK1G | 0.63676245 |
| 98 | MKNK2 | 0.62328783 |
| 99 | PDGFRA | 0.62267600 |
| 100 | MYLK | 0.62160043 |
| 101 | MKNK1 | 0.61898364 |
| 102 | PRKD1 | 0.61338747 |
| 103 | GRK1 | 0.61321022 |
| 104 | MARK2 | 0.60980765 |
| 105 | TIE1 | 0.60569197 |
| 106 | STK38 | 0.58850465 |
| 107 | CDK6 | 0.58838692 |
| 108 | TEC | 0.58838304 |
| 109 | AKT3 | 0.58764052 |
| 110 | PRKCI | 0.56558708 |
| 111 | PLK4 | 0.56460737 |
| 112 | CAMK1D | 0.55550271 |
| 113 | FGFR2 | 0.55085343 |
| 114 | MAP3K9 | 0.54489811 |
| 115 | MAP2K4 | 0.54411739 |
| 116 | PRKG1 | 0.52751994 |
| 117 | CAMK1 | 0.52386368 |
| 118 | BTK | 0.51743896 |
| 119 | PRKCH | 0.51321835 |
| 120 | PIK3CA | 0.51037881 |
| 121 | SYK | 0.50301444 |
| 122 | INSR | 0.50241043 |
| 123 | DMPK | 0.49504434 |
| 124 | CSNK1A1 | 0.49270370 |
| 125 | TRIM28 | 0.46929071 |
| 126 | NTRK1 | 0.46600375 |
| 127 | PRKACA | 0.46500172 |
| 128 | PRKG2 | 0.46318318 |
| 129 | BCR | 0.46303763 |
| 130 | CSNK1G1 | 0.46032282 |
| 131 | JAK1 | 0.44667163 |
| 132 | PRKCQ | 0.44062658 |
| 133 | MAP2K3 | 0.43948726 |
| 134 | TAOK1 | 0.42895067 |
| 135 | IRAK1 | 0.42310113 |
| 136 | DYRK1A | 0.42165694 |
| 137 | PRKCA | 0.40601464 |
| 138 | PLK2 | 0.40564090 |
| 139 | PRKCZ | 0.39852857 |
| 140 | DYRK3 | 0.39823236 |
| 141 | MAP2K2 | 0.39701027 |
| 142 | ERBB2 | 0.38083911 |
| 143 | MATK | 0.37578186 |
| 144 | CSNK1D | 0.37462469 |
| 145 | CDK3 | 0.37376919 |
| 146 | BMX | 0.37264618 |
| 147 | CAMK4 | 0.37109651 |
| 148 | RPS6KA5 | 0.34655904 |
| 149 | IKBKB | 0.33146517 |
| 150 | PRKAA2 | 0.32264098 |
| 151 | PRKACG | 0.32017894 |
| 152 | NEK1 | 0.31575474 |
| 153 | NEK9 | 0.31024405 |
| 154 | GRK5 | 0.30528471 |
| 155 | BRSK2 | 0.29626592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.60217350 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.87686495 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.62292298 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.51198991 |
| 5 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.05775431 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.81294051 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74488011 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.63326127 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.47345774 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.43984459 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.31881706 |
| 12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.94431653 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89229765 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 1.78683183 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.68019766 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57015586 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.51166935 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44956366 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44905361 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44587527 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.39013880 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35947822 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34636762 |
| 24 | Mineral absorption_Homo sapiens_hsa04978 | 1.33718233 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33193036 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30589445 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.29673358 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27726669 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26380762 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.25027315 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.22956135 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22689602 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19978035 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19645468 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.19520006 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 1.15461584 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.14264467 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12361472 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.11426949 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06240236 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03581416 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.03293958 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02469995 |
| 44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.00884968 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00447575 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00207429 |
| 47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99793347 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95667273 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95500804 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 0.94727136 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93546854 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90455145 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.86746343 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84755139 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84450330 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83791803 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83003856 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78552784 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78381623 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77394604 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76760157 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74983985 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.72240346 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72183270 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71820305 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71480133 |
| 67 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69968485 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69666287 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.69110628 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66717898 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66223359 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.65690475 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65312656 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64264644 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64251957 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63718597 |
| 77 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63405109 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62475796 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61697930 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61369900 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.60585063 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.60346451 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60181949 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59244344 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58714089 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57778965 |
| 87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56014812 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.55667002 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55506815 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53843759 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53674345 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52896120 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.52845159 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52617076 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52235590 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51882031 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51856751 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.50213906 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.48926990 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.47543994 |
| 101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47529137 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46981507 |
| 103 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46783728 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46689197 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46505808 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45237935 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44232699 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43767322 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43733087 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43569282 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.43543380 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43539786 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43412810 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41256497 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40580206 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40371938 |
| 117 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39997978 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39644740 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38708637 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37917755 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37603193 |
| 122 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37484367 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37460073 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37459568 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37307901 |
| 126 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36831754 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36382719 |
| 128 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36012293 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35356313 |
| 130 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33525268 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32436618 |

